Magenta Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Magenta Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB) (NCT05223699) | Magenta Therapeutics, Inc. | 2022-02-14 |
| A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) With MGTA-456 (NCT04008849) | Magenta Therapeutics, Inc. | 2019-05-21 |
| MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT) (NCT03406962) | Magenta Therapeutics, Inc. | 2018-02-09 |
Track Magenta Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.